Mode
Text Size
Log in / Sign up

Dog-assisted therapy significantly improves behavioral symptoms in dementia patients compared to routine care in a systematic reviewDog-assisted therapy improves behavior in dementia patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider dog-assisted therapy as a non-pharmacological intervention in long-term care facilities for dementia patients.

This systematic review and meta-analysis evaluated the impact of dog-assisted therapy on patients with dementia. The analysis included 10 randomized controlled trials comparing dog-assisted therapy to routine care. The primary outcome was behavioral and psychological symptoms of dementia, while secondary outcomes included functional activity, cognitive function, agitation, and depressive symptoms. The review found that behavioral and psychological symptoms of dementia were significantly improved compared to routine care, with a standardized mean difference of -0.46 and a p-value less than .0001. Functional activity was enhanced with a standardized mean difference of 0.31 and a p-value of .03. Agitation and depressive symptoms were also significantly alleviated. Conversely, cognitive function showed no statistically significant difference between the groups. Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. The setting of the studies was not reported. Funding or conflicts of interest were not reported.

A systematic review analyzed ten randomized controlled trials involving patients with dementia. The researchers compared dog-assisted therapy to routine care to see how it affected behavior and daily life. The analysis included long-term follow-up data where available.

The review found that dog-assisted therapy significantly improved behavioral and psychological symptoms compared to routine care. Patients also showed better functional activity and less agitation or depressive symptoms. However, the therapy did not show a clear difference in cognitive function.

No serious safety concerns were reported in the included studies. Despite these positive results, the overall evidence is considered relatively weak because the underlying studies had small sample sizes and a high risk of bias. Experts caution that clinical benefits need long-term follow-up to fully verify before widespread adoption.

This meta-analysis suggests that dog-assisted therapy could be a useful non-pharmacological option for long-term care facilities. However, patients and families should understand that the current data has limitations and does not prove the therapy works for everyone.

What this means for you:
Dog-assisted therapy may help dementia behavior, but evidence is weak and needs more long-term study.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Patients with dementia commonly exhibit behavioral and psychological symptoms of dementia (BPSD) such as depression, withdrawal, and agitation. These symptoms are known to significantly impact both mental and physical health, increase caregiving burdens, and lead to higher rates of hospitalization and mortality. PURPOSE: This study was designed to evaluate using a systematic review and meta-analysis the effectiveness of dog-assisted therapy (DAT) in improving BPSD. METHODS: In line with the Joanna Briggs Institute guidelines for systematic reviews of effectiveness, a literature search was conducted in seven databases, including AgeLine, CINAHL, Cochrane Library, Embase, ProQuest, PubMed, and Airiti Library for relevant articles in Chinese or English published before April 2025. The keywords "dementia", "dog-assisted therapy", and their related MeSH terms and synonyms were used. The scope of the search was limited to randomized controlled trials (RCTs), with studies not meeting the criteria were excluded. A total of 10 RCTs were included. The literature was assessed using the Joanna Briggs Institute 2023 RCT appraisal checklist, the Grading of Recommendations Assessment, Development and Evaluation system was used to rate the quality of the evidence, and the meta-analysis was performed using RevMan version 5.4. RESULTS: The results of the meta-analysis revealed that DAT improved BPSD significantly compared to routine care (SMD = -0.46, p < .0001) and enhanced functional activity (SMD = 0.31, p = .03). However, no statistically significant difference was found in terms of cognitive function. The subgroup analysis results for BPSD indicate DAT significantly alleviates agitation and depressive symptoms. CONCLUSIONS / IMPLICATIONS FOR PRACTICE: The findings indicate DAT has the potential to significantly improve BPSD in patients with dementia. However, the existing evidence relies primarily on small sample studies with an overall high risk of bias, making the evidence relatively weak. Based on current evidence, DAT should be used as a non-pharmacological care intervention in long-term care facilities, with long-term follow-up necessary to verify its clinical application benefits.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.